Lung Cancer Clinical Trial
Official title:
A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery
Verified date | March 2019 |
Source | Dartmouth-Hitchcock Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The paradigm of pre-operative exercise as a neoadjuvant therapy to reduce morbidity is
increasingly promoted within general surgery and surgical oncology.
Patients with lung cancer participating in pre-operative exercise have better aerobic
capacity and pulmonary function and shorter hospital length-of-stay after surgery.
Additionally, pre-operative exercise may increase the likelihood of resuming exercise
post-surgery, thereby accelerating the pace of rehabilitation and recovery.
In order to translate the research findings into sustainable clinical practice,
clinician-scientists need to develop pragmatic and effective home-based exercise protocols.
Wearable fitness devices offer a way to approximate the supervision that occurs in exercise
research.
Before the investigators can develop an intervention in which patients receive tailored
support similar to what occurs with supervised exercise, they need to pilot test the
monitoring aspect of the wearable fitness device in conjunction with the pre-operative
exercise program. The investigators propose a mixed methods, 16 single arm feasibility study
of an unsupervised, pre-operative exercise prescription (uPEP) augmented by a wearable
fitness device. The proposed study of 30 patients scheduled for lung cancer surgery will
identify the strengths, weaknesses, and utility of this approach.
Status | Completed |
Enrollment | 30 |
Est. completion date | February 5, 2019 |
Est. primary completion date | February 5, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - This study will recruit English-speaking patients who: 1. Are over the age of 18 and diagnosed with Stage I-III lung cancer; 2. Are able to tolerate surgery (i.e., segmentectomy, lobectomy or bilobectomy) as indicated by standard clinical pre-op evaluation, including pulmonary function tests and cardiac evaluation (if indicated); 3. Access to either Wi-Fi or cellular service and permission/ability to download the wearable fitness device app on an apple device, android, or computer (or willingness to use a study-provided iPod to allow the data to be uploaded to the study team); 4. Are able to provide voluntary, written consent. Exclusion Criteria: - Participants will be excluded based on electronic health record (EHR) review (after obtaining HIPAA waiver) if they: 1. Have a life expectancy of < 12 months or are receiving hospice services; 2. Have a psychiatric diagnosis that would require significant study modification to meet their needs such as uncontrolled severe mental illness, substance abuse, or active suicidal ideation; 3. Exhibit American College of Sports Medicine contraindications to exercise which include a resting heart rate of >120bpm, blood pressure >180/100mmHg or unstable angina;31 4. Are unable to walk or to complete the 6-minute walk test. According to our current standard of care, those participants will be referred to physical therapy for evaluation and treatment and will be excluded from the study as unsupervised exercise would not be safe. |
Country | Name | City | State |
---|---|---|---|
United States | Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire |
Lead Sponsor | Collaborator |
---|---|
Dartmouth-Hitchcock Medical Center | Dartmouth College, Norris Cotton Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adherence to exercise: | number of completed pre-operative exercise sessions divided by number of prescribed sessions, according to exercise log | Time 3, day of surgery | |
Secondary | Feasibility of recruitment: | number of patients enrolled divided by number of patients eligible | Time 5, 16 weeks post-surgery | |
Secondary | Acceptance of technology | number of hours the fitness tracker was worn in pre-operative period | Time 3, day of surgery | |
Secondary | Participant perception of exercise program | semi-structured interview regarding perceptions of the exercise program | Time 2, 3-5 days before surgery | |
Secondary | Participant perception of fitness tracker | semi-structured interview regarding perceptions of the fitness tracker | Time 2, 3-5 days before surgery | |
Secondary | Subjective minutes spent in exercise | Number of minutes spent in exercise according to exercise log | Time 3, day of surgery | |
Secondary | Objective minutes spent in exercise: | Number of minutes spent in exercise according to fitness tracker | Time 3, day of surgery | |
Secondary | Aerobic capacity: | Six minute walk test | Time 3, day of surgery | |
Secondary | Pulmonary function: | Diffusion of lungs for carbon monoxide test | Time 2, 3-5 days before surgery | |
Secondary | Subjective physical function: | PROMIS (Patient-Reported Outcomes Measurement Information System) physical function scale | Time 2, 3-5 days before surgery | |
Secondary | Objective physical function: | Grip strength per dynamometer | Time 3, day of surgery | |
Secondary | Length of stay in hospital: | Number of days from surgery to discharge home | Time 4, 2 weeks post-surgery | |
Secondary | Feasibility of Retention | Number of patients completing all study assessments divided by the number enrolled | 16 weeks post-surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|